(From left to right) Top: James Iannuzzi, MD; Christy Feigenbutz, NP; Laura Ellis, NP; Joanna Delong, NP; Camille Jackson, MD; Maunil Bhatt, MD. Middle: Clara Gomez-Sanchez, MD; Rebecca Buti, NP; Shant Vartanian, MD; Adam Oskowitz, MD; Charles Eichler, MD; Iris Liu, MD; Elizabeth Anderson, NP. Bottom: Warren Gasper, MD; Jade Hiramoto, MD; Michael Conte, MD; Linda Reilly, MD; Colleen Flanagan, MD; Joel Ramirez, MD.

Message from the Chief

The Division of Vascular & Endovascular Surgery is an integral part of the UCSF Heart and Vascular Center, a multidisciplinary program which brings together vascular surgeons and other cardiovascular specialists to provide the most advanced and effective treatments for vascular disorders. Faculty members in the Division have achieved national and international recognition as leaders in clinical innovation, surgical education, and research.

Important Update for Our Referring Physicians on COVID-19

We offer diagnosis and treatment of a complete range of vascular disorders, including arterial blockages (peripheral artery disease, or PAD), aneurysms, carotid artery disease, hemodialysis access procedures, and venous disease. In addition, we have expertise in less-common disorders including complex thoracoabdominal aortic aneurysms that involve the upper abdomen and chest, hyperhidrosis, arterial graft infections, blockages of the arteries to the kidneys or intestines and thoracic outlet syndrome (TOS).

UCSF Vascular Surgery, in continuous practice since 1951, has long set the standard for treatment of complex problems such as aortic aneurysms extending above the kidneys and blockages of the arteries to the intestines and kidneys. This tradition of excellence and innovation continues with our development of safer and less-invasive techniques for treating vascular disease, including our endovascular aneurysm repair program, catheter-based treatment of arterial blockages, and minimally invasive treatments for varicose veins/venous disease. The Division's research program is a leader in the development of device technology for aneurysms, as well as novel biologic therapies to improve the outcomes of bypass surgery, promote new blood vessel growth, and ameliorate the progression of PAD. 

Michael S. Conte, M.D.
Professor and Chief,
Division of Vascular & Endovascular Surgery
Edwin J. Wylie, M.D. Chair in Vascular Surgery
Co-Director, UCSF Heart and Vascular Center
Co-Director, UCSF Center for Limb Preservation